Bank of America’s Perspective Therapeutics CATX Stock Holding History

Bank of America’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Sell	241,924 -182,595	-43%	-$771K	﹤0.01%	4523
2025 Q4	$1.17M	Sell	424,519 -361,304	-46%	-$1.03M	﹤0.01%	4425
2025 Q3	$2.7M	Buy	785,823 +458,323	+140%	+$1.67M	﹤0.01%	4557
2025 Q2	$1.13M	Buy	327,500 +25,697	+9%	+$67.8K	﹤0.01%	5218
2025 Q1	$643K	Buy	301,803 +253,026	+519%	+$759K	﹤0.01%	5513
2024 Q4	$156K	Sell	48,777 -125,567	-72%	-$1.03M	﹤0.01%	6225
2024 Q3	$2.33M	Buy	174,344 +106,689	+158%	+$1.42M	﹤0.01%	4448
2024 Q2	$675K	Buy	67,655 +48,427	+252%	+$700K	﹤0.01%	5155
2024 Q1	$229K	Buy	19,228 +19,211	+113,006%	+$164K	﹤0.01%	5811
2023 Q4	$67	Buy	+17	New	+$48	﹤0.01%	7457
2023 Q1	–	Sell	-34	Closed	-$82	–	7838
2022 Q4	$82	Buy	+34	New	+$112	﹤0.01%	7704
2022 Q3	–	Sell	-100	Closed	–	–	7853
2022 Q2	$0	Buy	+100	New	+$305	﹤0.01%	8037
2022 Q1	–	Sell	-21	Closed	–	–	8285
2021 Q4	$0	Sell	21 -51	-71%	-$272	﹤0.01%	8243
2021 Q3	$0	Buy	72 +65	+929%	+$443	﹤0.01%	8122
2021 Q2	$0	Buy	+7	New	+$61	﹤0.01%	7765
2020 Q4	–	Sell	-186	Closed	-$1K	–	7104
2020 Q3	$1K	Sell	186 -314	-63%	-$2.05K	﹤0.01%	6752
2020 Q2	$3K	Hold	500	–	–	﹤0.01%	6608
2020 Q1	$3K	Buy	+500	New	+$3.77K	﹤0.01%	6565
2019 Q4	–	Sell	-237	Closed	-$1K	–	7100
2019 Q3	$1K	Buy	237 +231	+3,850%	+$837	﹤0.01%	7081
2019 Q2	$0	Buy	+6	New	+$25	﹤0.01%	7194
2018 Q3	–	Sell	-1,000	Closed	-$5K	–	7270
2018 Q2	$5K	Hold	1,000	–	–	﹤0.01%	6792
2018 Q1	$4K	Hold	1,000	–	–	﹤0.01%	6799
2017 Q4	$4K	Hold	1,000	–	–	﹤0.01%	6756
2017 Q3	$5K	Sell	1,000 -200	-17%	-$1.12K	﹤0.01%	6719
2017 Q2	$7K	Sell	1,200 -300	-20%	-$1.7K	﹤0.01%	6514
2017 Q1	$9K	Hold	1,500	–	–	﹤0.01%	6559
2016 Q4	$9K	Sell	1,500 -59	-4%	-$361	﹤0.01%	6577
2016 Q3	$11K	Buy	1,559 +59	+4%	+$449	﹤0.01%	6345
2016 Q2	$13K	Hold	1,500	–	–	﹤0.01%	6410
2016 Q1	$14K	Hold	1,500	–	–	﹤0.01%	6268
2015 Q4	$14K	Buy	1,500 +500	+50%	+$6.23K	﹤0.01%	6555
2015 Q3	$14K	Hold	1,000	–	–	﹤0.01%	6444
2015 Q2	$15K	Hold	1,000	–	–	﹤0.01%	6442
2015 Q1	$16K	Hold	1,000	–	–	﹤0.01%	6126
2014 Q4	$15K	Hold	1,000	–	–	﹤0.01%	6892
2014 Q3	$17K	Hold	1,000	–	–	﹤0.01%	7122
2014 Q2	$31K	Sell	1,000 -520	-34%	-$13K	﹤0.01%	6949
2014 Q1	$33K	Buy	1,520 +489	+47%	+$4.97K	﹤0.01%	6656
2013 Q4	$5K	Buy	1,031 +31	+3%	+$163	﹤0.01%	7468
2013 Q3	$7K	Sell	1,000 -4	-0.4%	-$25	﹤0.01%	7279
2013 Q2	$5K	Buy	+1,004	New	+$5.41K	﹤0.01%	7354

Other funds holding CATX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America's CATX Position: Q1 2026 in Review

Bank of America reduced its Perspective Therapeutics (CATX) stake by 43% in Q1 2026, selling an estimated $771K and leaving 241,924 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4523.

Bank of America first reported a position in CATX in Q2 2013 and has held it in 41 quarters since. The position peaked at $2.7M in Q3 2025. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

Bank of America held 241,924 shares of Perspective Therapeutics worth $1.01M as of Q1 2026.
Bank of America sold 182,595 Perspective Therapeutics shares in Q1 2026, an estimated $771K.
Perspective Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4523 holding.
Bank of America first reported a position in Perspective Therapeutics in Q2 2013 and has held it in 41 quarters since.
Bank of America's Perspective Therapeutics position peaked at $2.7M in Q3 2025.
138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.